These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16193577)
1. Aptivus in the hotseat. Excerpts from the FDA hearings. Huff B GMHC Treat Issues; 2005; 19(5-6):6-8. PubMed ID: 16193577 [No Abstract] [Full Text] [Related]
2. Aptivus capsules granted full FDA approval. AIDS Patient Care STDS; 2007 Nov; 21(11):889-90. PubMed ID: 18338430 [No Abstract] [Full Text] [Related]
3. FDA approves Aptivus (tipranavir). Pham PA Hopkins HIV Rep; 2005 Jul; 17(4):6-7. PubMed ID: 16419308 [No Abstract] [Full Text] [Related]
6. FDA approval: tipranavir. Sax PE AIDS Clin Care; 2005 Aug; 17(8):78. PubMed ID: 16193574 [No Abstract] [Full Text] [Related]
7. New black box warning for ritonavir-boosted tipranavir. Ryan CT AIDS Clin Care; 2006 Aug; 18(8):72. PubMed ID: 16906669 [No Abstract] [Full Text] [Related]
8. New protease inhibitor offers clinicians hope for better salvage therapy. Murphy MJ HIV Clin; 2006; 18(1):1-3. PubMed ID: 16838417 [No Abstract] [Full Text] [Related]
9. FDA notifications. Accelerated approval of tipranavir. AIDS Alert; 2005 Nov; 20(11):131. PubMed ID: 16363051 [No Abstract] [Full Text] [Related]